10Jul 2026
Antimicrobial-Resistant Neonatal Sepsis Study Begins
STUDY TO CONTAIN ANTIMICROBIAL-RESISTANT NEONATAL SEPSIS BEGINS IN INDIA Why in the News? India Joins Global Trial: India has joined the NeoSep1 international clinical trial to evaluate effective antibiotic combinations for antimicrobial-resistant neonatal sepsis, with the first participants enrolled at JIPMER, Puducherry and PGIMS, Rohtak, demonstrating strategic alignment with global health priorities. Public Health Significance: …
Read More
